Squarepoint’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$156K Sell
24,440
-203,496
-89% -$1.3M ﹤0.01% 2397
2025
Q1
$1.11M Buy
227,936
+180,718
+383% +$878K ﹤0.01% 1452
2024
Q4
$451K Sell
47,218
-163,227
-78% -$1.56M ﹤0.01% 1983
2024
Q3
$1.76M Sell
210,445
-20,569
-9% -$172K ﹤0.01% 1177
2024
Q2
$1.58M Buy
+231,014
New +$1.58M ﹤0.01% 1169
2024
Q1
Sell
-79,181
Closed -$190K 2550
2023
Q4
$190K Sell
79,181
-508,220
-87% -$1.22M ﹤0.01% 2150
2023
Q3
$2M Buy
587,401
+538,599
+1,104% +$1.83M ﹤0.01% 972
2023
Q2
$359K Buy
48,802
+22,071
+83% +$162K ﹤0.01% 1770
2023
Q1
$277K Buy
26,731
+16,322
+157% +$169K ﹤0.01% 1723
2022
Q4
$123K Sell
10,409
-3,771
-27% -$44.5K ﹤0.01% 2024
2022
Q3
$298K Buy
+14,180
New +$298K ﹤0.01% 1631
2022
Q1
Sell
-6,661
Closed -$290K 2378
2021
Q4
$290K Buy
6,661
+3
+0% +$131 ﹤0.01% 1882
2021
Q3
$333K Buy
+6,658
New +$333K ﹤0.01% 1583
2021
Q2
Sell
-21,958
Closed -$2.04M 2719
2021
Q1
$2.04M Buy
+21,958
New +$2.04M 0.01% 724
2020
Q4
Sell
-15,785
Closed -$1.63M 2605
2020
Q3
$1.63M Sell
15,785
-28,355
-64% -$2.93M 0.02% 713
2020
Q2
$3.49M Buy
44,140
+12,177
+38% +$963K 0.06% 451
2020
Q1
$1.85M Buy
31,963
+21,418
+203% +$1.24M 0.05% 462
2019
Q4
$569K Buy
10,545
+3,974
+60% +$214K ﹤0.01% 1650
2019
Q3
$344K Sell
6,571
-33,741
-84% -$1.77M ﹤0.01% 1752
2019
Q2
$1.95M Buy
+40,312
New +$1.95M 0.02% 852
2019
Q1
Sell
-5,762
Closed -$342K 2159
2018
Q4
$342K Sell
5,762
-3,727
-39% -$221K ﹤0.01% 1426
2018
Q3
$625K Buy
+9,489
New +$625K 0.01% 1205
2018
Q1
Sell
-29,928
Closed -$1.39M 1783
2017
Q4
$1.39M Buy
29,928
+4,558
+18% +$212K 0.02% 674
2017
Q3
$1.03M Buy
+25,370
New +$1.03M 0.02% 701
2017
Q1
Sell
-11,967
Closed -$393K 1596
2016
Q4
$393K Buy
+11,967
New +$393K 0.02% 963
2016
Q3
Sell
-57,959
Closed -$1.63M 1070
2016
Q2
$1.63M Buy
+57,959
New +$1.63M 0.1% 235
2016
Q1
Sell
-13,515
Closed -$541K 1225
2015
Q4
$541K Buy
+13,515
New +$541K 0.06% 497